Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiao-Kang Lu

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Anatomical Record (Hoboken, N.J. : 2007)|March 4, 2023
First report on rhinoceros from the late Neogene Qin Basin of Shanxi, ChinaBao-Zhong Shi, Shao-Kun Chen, Xiao-Kang Lu, et al.
Iscience|September 25, 2023
Reproduction of a fossil rhinoceros from 18 mya and origin of litter size in perissodactylsXiao-Kang Lu, Tao Deng, Paul Rummy, et al.
Environmental Toxicology|February 27, 2026
DEHP Exposure Affects Mitochondrial Function During Ovarian Follicle DevelopmentShu-Jie Yang, Xiao-Kang Lu, Li-Shu Li, et al.
National Science Review|July 1, 2026
A multienzyme-mimicking nanoplatform induces disulfidptosis/cuproptosis/apoptosis for tumor therapyWei-Jie Sun, Jie Lin, Xiao-Kang Lu, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2013
Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitorsMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2013
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacyMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Anatomical Record (Hoboken, N.J. : 2007)|March 4, 2023
First report on rhinoceros from the late Neogene Qin Basin of Shanxi, ChinaBao-Zhong Shi, Shao-Kun Chen, Xiao-Kang Lu, et al.
Iscience|September 25, 2023
Reproduction of a fossil rhinoceros from 18 mya and origin of litter size in perissodactylsXiao-Kang Lu, Tao Deng, Paul Rummy, et al.
Environmental Toxicology|February 27, 2026
DEHP Exposure Affects Mitochondrial Function During Ovarian Follicle DevelopmentShu-Jie Yang, Xiao-Kang Lu, Li-Shu Li, et al.
National Science Review|July 1, 2026
A multienzyme-mimicking nanoplatform induces disulfidptosis/cuproptosis/apoptosis for tumor therapyWei-Jie Sun, Jie Lin, Xiao-Kang Lu, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2013
Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitorsMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2013
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacyMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Pageof 1